Braskem S.A. Sponsored ADR
Braskem S.A. Sponsored ADR Class A is a Brazilian chemical and petrochemical company that produces and sells a broad range of industrial materials used across packaging, construction, automotive, consumer goods, and infrastructure markets. Braskem focuses on petrochemicals, thermoplastic resins, and related products, serving customers that rely on basic inputs for manufacturing and processing operations. The company also participates in the production, import, export, and commercialization of fuels, along with utility-related services such as steam, water, compressed air, and industrial gases for industrial use. With operations extending across Brazil, the United States, Europe, and Mexico, Braskem plays a significant role in supplying essential materials to global supply chains. Braskem S.A. Sponsored ADR Class A represents the company’s U.S.-traded depositary shares, providing market access to its business in the chemicals and specialty materials sector.
$1.70
+$0.10 (+6.25%)
EOD Oct 23, 2026
Operating margin is thin at 4.39%. Limited cushion if revenue slows or costs rise.
Revenue declined 8.6% in the fiscal year ended Dec 2025. Margins deteriorated 3.5pp alongside, both lines moving the wrong way.
ROIC fell 2.8 points in the fiscal year ended Dec 2025, capital efficiency is deteriorating. Negative free cash flow of -BRL 8.94B. The business is consuming cash, not generating it.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
BRL 70.60B
▼ -8.6% YoY
Net Income (TTM)
-BRL 6.63B
▲ +9.1% YoY
Op. Margin
4.39%
▼ -3.5pp YoY
ROIC
-1.79%
▼ -2.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-BRL 8.94B
▼ -452.9% YoY
Op. Cash Flow (TTM)
-BRL 5.80B
▼ -168.0% YoY
Net Debt
BRL 59.48B
Cash & Equiv.
BRL 11.84B
3Y CAGR: -9.8%
Continue Research
Is Braskem S.A. Sponsored ADR (BAK) overvalued?
Braskem S.A. Sponsored ADR (BAK)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Braskem S.A. Sponsored ADR scores 13/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Braskem S.A. Sponsored ADR a high-quality business?+
Braskem S.A. Sponsored ADR scores 13 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 4.4% operating margin and a -1.8% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Braskem S.A. Sponsored ADR a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh BAK's valuation and scores 13/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Chemicals
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BAK
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.